Search
Press release
VISIOMER
April 8, 2014

Evonik: new product family VISIOMER® Terra

  • VISIOMER® Terra – methacrylate monomers based on renewable resources
  • Starting with three products: VISIOMER® Terra IBOMA, VISIOMER® Terra C13-MA, and VISIOMER® Terra C17.4-MA

Evonik Industries, one of the world’s leading providers of products based on methacrylate chemistry, will be presenting its new line of VISIOMER® Terra products at the American Coatings Show in Atlanta, Georgia. On March 1, 2014, the Acrylic Monomers Business Line began bundling methacrylate monomers based to a significant degree on renewable resources under the product family VISIOMER® Terra.

VISIOMER® Terra showcases the partially bio-based products that are already part of the Acrylic Monomers’ portfolio and is expected to continue growing in the future. "Thanks to VISIOMER® Terra, we can already offer our customers products that combine outstanding properties for end-use applications with a source of bio-based raw materials. Developing new products based on renewable resources is a fixed component of our development work. We also continuously evaluate potential options for manufacturing existing products from bio-based raw materials," explains Hans-Peter Hauck, head of the Acrylic Monomers Business Line.

VISIOMER® Terra IBOMA allows manufacturers to formulate environmentally safe coatings while keeping VOC content low. VISIOMER® Terra C17.4-MA and VISIOMER® Terra C13-MA increase hydrophobicity in resin systems, thereby improving resistance to water and solvents.

In addition to the broad portfolio of specialty methacrylates that Evonik Industries produces and markets throughout the world under the VISIOMER® name, the brand also includes MMA, GMAA, n- and i-BMA, and hydroxy methacrylates.

Please see our website for more information: www.visiomer.com.

Company information

Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.

Evonik is active in over 100 countries around the world. In fiscal 2013 more than 33,500 employees generated sales of around €12.9 billion and an operating profit (adjusted EBITDA) of about €2.0 billion.

Disclaimer

In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.